Shanghai Auson Pharmaceuticals

Shanghai Auson Pharmaceuticals is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end drug formulations and innovative medicines. The company is particularly recognized for its expertise in lipid-based drug delivery systems, including liposomal technology, which it applies to cardiovascular and anti-infective treatments. Its flagship product is a liposomal Alprostadil injection used for treating peripheral vascular diseases and other cardiovascular conditions. Auson operates modern, GMP-certified manufacturing facilities in Shanghai and maintains a strong focus on improving the safety and efficacy of established therapeutic agents through advanced formulation science.